Gilead (GILD): Earnings per share for the last twelve months

Corporate company logo of Gilead Sciences (GILD)

The annual net income per share of Gilead Sciences, Inc. (GILD) on the GURU.Markets chart reflects a trend where the value -3.15 serves as the baseline indicator. The primary risks for Gilead Sciences, Inc. (GILD) stem from a narrow portfolio of profitable drugs and patent threats. Management is focusing on dividends and the HIV segment, although expansion into oncology remains controversial. Stable core income is coupled with rising costs for new developments.

Gilead Sciences, Inc. (GILD) - Net earnings per share (EPS TTM) from 07/04/2022 to 11/18/2026

Analytical breakdowns for Gilead Sciences, Inc.

- stock price and consensus target price:
Fundamental company analysis:GILD - Gilead Sciences
Manufactured products of Gilead

Gilead Sciences, Inc. (GILD) leverages its dominance in the HIV segment to expand into oncology, which directly impacts its ability to generate profit. The 12-month net income per share trend digitizes the final financial result distributed across all outstanding shares, allowing investors to assess the actual efficiency of the business capitalization and the stability of its fundamental value.

Competitor analysis for Gilead Sciences, Inc.

Cidara Therapeutics Corp - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters Novavax Inc NVAX|CureVac Corp (CVAC) - Earnings per share for the last twelve months|Valneva SE - Earnings per share for the trailing year|Earnings per share for the last twelve months vir.bio|Net earnings per share (EPS TTM) siga.com|Net earnings per share (EPS TTM) EBS|Net earnings per share for the last four quarters Atea Pharmaceuticals, Inc.|Net earnings per share (EPS TTM) IVVD (invivyd.com)|Enanta Pharmaceuticals, Inc (ENTA) - Net earnings per one share for the last twelve months|INO - Earnings per share for the last twelve months|Net earnings per share for the last four quarters hillevax.com HLVX|Kalaris Therapeutics (KLRS) - Earnings per share for the last twelve months|Dyadic International Inc (DYAI) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months NanoViricides Inc.|Talphera Corp - Earnings per one share for the last 12 months|Net earnings per share for the last 12 months COCP (Cocrystal Pharma Inc)|Net earnings per share for the last four quarters Traws Therapeutics|Earnings per share for the last twelve months Dogwood Therapeutics DWTX|Net earnings per share for the trailing year Qualigen Therapeutics, Inc.|ALVR - Earnings per share for the last twelve months|vbivaccines.com (VBIV) - Net earnings per share for the last 12 months|VIRI (virios.com) - Net earnings per share for the last 12 months|VXRT - Net earnings per share for the last four quarters